Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of mirogabalin for diabetic peripheral neuropathic pain, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirogabalin (mirogabalin besilate)

Snippet

Sponsor: Bangladesh Medical University | Conditions: Diabetic Peripheral Neuropathic Pain (DPNP) | Phase 4 | Status: RECRUITING